Adverse reactions : תופעות לוואי

4.8   Undesirable effects
Side effects may occur as signs of overdose, see section 4.9.
Definition of frequency terms used in this section:
Rare: (≥ 1/10,000, < 1/1,000)
Not known (cannot be estimated from the available data)
Immune system disorders
Frequency not known: Hypersensitivity reactions characterised by urticaria have been occasionally described after the intravenous administration of magnesium salts.


Gastrointestinal disorders
Although oral magnesium salts stimulate peristalsis, rare cases of paralytic ileus have been reported after intravenous infusion of magnesium sulphate.
General disorders and administration site conditions
Adverse reactions may be associated with the administration technique and include febrile response, infection at the site of injection, local pain or reactions, vein irritation, venous thrombosis or phlebitis extending from the site of injection and extravasation.
Adverse reactions may be associated with the medications added to the solution; the nature of the additive will determine the likelihood of any other undesirable effects.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Any suspected adverse events should be reported to the Ministry of Health according to the National Regulation by using an online form
(https://sideeffects.health.gov.il)